您的位置: 首页 > 农业专利 > 详情页

DRUG COMBINATIONS FOR TARGETING MULTIPLE MUTATIONS IN CANCER
专利权人:
CureMatch; Inc.
发明人:
Igor Flint Tsigelny,Amélie Clémence Boichard,Kevin Toivo Busch
申请号:
US16638122
公开号:
US20200237764A1
申请日:
2018.08.13
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Disclosed are methods for treating a cancer in a patient. The method comprises: (a) defining a set of substances targeting pathogenic genes identified by screening of a sample of cancer cells from a patient by NGS or other technique, (b) identifying two or more target genes in the cancer cells, each of which containing an actionable mutation and (c) testing, using in vitro culture cell experiments, the efficacy of one or more substances (administered sequentially or concurrently) targeting the actionable mutation for each of the two or more target genes identified and (d) designating potential efficacious therapeutic options that will be used to treat the patient's cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充